Lannett Company Inc Revenue per Employee (LCINQ), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lannett Company Inc  (NONE: LCINQ)
 

Lannett Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 1.41% in the third quarter 2023, year on year to cumulative value of $300 million, Lannett Inc's revenue per employee grew on a trailing twelve months basis to $ 2,588,336, this is below the company average.
Within the Healthcare sector Employees of 20 other companies have achieved higher revenue per employee. While Lannett Inc's total ranking has deteriorated compared to the previous quarter from 0 to 329. Lannett Inc has 116 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LCINQ Revenue per Employee (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter		 (Sep 30 2022)
I. Quarter		 (Jun 30 2022)
IV. Quarter		 (Mar 31 2022)
III. Quarter
Y / Y Revenue Change 1.41 % -15.95 % -27.23 % -30.02 % -30.27 %
Sales per Employee (TTM) $ 2,588,336 2,578,793 2,697,741 2,936,026 3,210,336
LCINQ's Total Ranking # 329 # 0 # 0 # 0 # 0
Seq. Revenue Change 9.29 % -1.59 % -0.41 % -5.32 % -9.42 %

LCINQ Company Profile >> Back to LCINQ Efficiency Comparisons >> Compare LCINQ Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 21
Overall Market # 329

Revenue per Employee Statistics
High Average Low
$ 5,716,466 $ 3,578,805 $ 1,700,310
(Mar 31 2017)   (Jun 30 2020)



Financial Statements
Lannett Inc's Revenue MRQ $ 79 Millions Visit LCINQ's Income Statement
Lannett Inc's Revenues TTM $ 300 Millions Visit LCINQ's aggregate revenue growth
What are LCINQ's Sales? Visit LCINQ's Sales by Segment




Other Ratios
Lannett Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LCINQ's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LCINQ's Competitors
Revenue per Employee for LCINQ's Suppliers
Revenue per Employee for LCINQ's Customers

You may also want to know
LCINQ's Sales Growth Rates LCINQ's Pe Price to earnings ratio LCINQ's Receivables Turnover Ratio LCINQ's Stock Quote
LCINQ's Net Income Growth Rates LCINQ's Ps Price to Sales ratio LCINQ's Sales per Employee LCINQ's Asset Turnover Ratio
LCINQ's Net Margin LCINQ's Pb Price to Book ratio LCINQ's Financial Strength Ratios LCINQ's Dividend Payout Ratio
Date modified: 2026-08-29T17:13:42+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2023Number of Employees Mar 31 2023
Atara Biotherapeutics Inc   4,322,357.14 $ 60.513  Million 14 
Ironwood Pharmaceuticals inc   4,171,280.00 $ 417.128  Million 100 
Ligand Pharmaceuticals Incorporated  4,138,957.45 $ 194.531  Million 47 
Cue Health Inc   4,110,387.50 $ 328.831  Million 80 
Community Health Systems Inc   3,938,064.52 $ 12,208.000  Million 3,100 
Agilon Health Inc   3,727,702.10 $ 3,190.913  Million 856 
Tvardi Therapeutics Inc   3,603,500.00 $ 43.242  Million 12 
Illumina Inc   3,475,000.00 $ 4,448.000  Million 1,280 
P3 Health Partners Inc   3,368,761.46 $ 1,078.004  Million 320 
Pulmatrix Inc   3,205,000.00 $ 6.410  Million 2 
Moderna Inc   3,204,042.55 $ 15,059.000  Million 4,700 
Assertio Holdings inc   3,059,660.38 $ 162.162  Million 53 
Akumin Inc   2,812,584.27 $ 750.960  Million 267 
Horizon Therapeutics Public Limited Company  2,750,660.00 $ 3,575.858  Million 1,300 
Lannett Company Inc  2,588,336.21 $ 300.247  Million 116 
Marker Therapeutics inc   2,556,711.60 $ 12.784  Million 5 
Arcturus Therapeutics Holdings Inc   2,531,891.89 $ 281.040  Million 111 
Dynavax Technologies Corporation  2,380,421.82 $ 654.616  Million 275 
Paratek Pharmaceuticals Inc   2,347,084.51 $ 166.643  Million 71 
Babylon Holdings Limited  2,308,686.00 $ 1,154.343  Million 500 
Eagle Pharmaceuticals inc   2,282,401.71 $ 267.041  Million 117 
Morphic Holding inc   2,224,096.77 $ 68.947  Million 31 
Siga Technologies Inc  2,215,496.65 $ 108.559  Million 49 
Shockwave Medical Inc   2,202,245.06 $ 557.168  Million 253 
Barinthus Biotherapeutics Plc  2,153,785.71 $ 30.153  Million 14 
Matinas Biopharma Holdings Inc   2,142,000.00 $ 4.284  Million 2 
Spero Therapeutics Inc   2,140,360.00 $ 53.509  Million 25 
Sorrento Therapeutics Inc   2,023,533.33 $ 60.706  Million 30 
Petros Pharmaceuticals inc   2,014,947.00 $ 6.045  Million 3 
Amgen Inc   2,014,615.38 $ 26,190.000  Million 13,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.